Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Alteplase, sold under the brand name Activase among others, is a biosynthetic form of human tissue-type plasminogen activator (t-PA). It is a thrombolytic medication used to treat acute ischemic stroke, acute ST-elevation myocardial infarction (a type of heart attack), pulmonary embolism associated with low blood pressure, and blocked central venous…
History, Community, Culture & Applications
Explore the main themes, entities and connections around Alteplase. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
ischemic stroke plasminogen acute used catheter activator blood treatment blocked may treat adverse pulmonary embolism administration t-pa thrombolytic fibrinolysis catheters
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Alteplase | AHFS/Drugs.com | Monograph | 1.00 | infobox |
| Alteplase | ATC code | B01AD02 (WHO) S01XA13 (WHO) | 1.00 | infobox |
| Alteplase | CAS Number | 105857-23-6 | 1.00 | infobox |
| Alteplase | ChemSpider | none | 1.00 | infobox |
| Alteplase | Drug class | Tissue plasminogen activator | 1.00 | infobox |
| Alteplase | DrugBank | DB00009 | 1.00 | infobox |
| Alteplase | Formula | C2569H3928N746O781S40 | 1.00 | infobox |
| Alteplase | KEGG | D02837 | 1.00 | infobox |
| Alteplase | Legal status | AU: S4 (Prescription only) | 1.00 | infobox |
| Alteplase | Legal status | CA: ℞-only | 1.00 | infobox |
| Alteplase | Legal status | US: ℞-only | 1.00 | infobox |
| Alteplase | Legal status | EU: Rx-only | 1.00 | infobox |
| Alteplase | License data | US DailyMed: Alteplase | 1.00 | infobox |
| Alteplase | MedlinePlus | a625001 | 1.00 | infobox |
| Alteplase | Molar mass | 59042.52 g·mol−1 | 1.00 | infobox |
| Alteplase | Other names | t-PA, rt-PA | 1.00 | infobox |
| Alteplase | Pregnancy category | AU: B1 | 1.00 | infobox |
| Alteplase | Routes of administration | Intravenous | 1.00 | infobox |
| Alteplase | Trade names | Activase, others | 1.00 | infobox |
| Alteplase | UNII | 1RXS4UE564 | 1.00 | infobox |
| Alteplase | causes | the breakdown of a clot by inducing fibrinolysis.It is on the World Health Organization's List of Essential Medicines | 0.90 | text |
| Alteplase | is a | same as the normal human plasminogen activator produced in vascular endothelial cells and is synthesized via recombinant DNA technology in Chinese hamster ovary cells | 0.90 | text |
| Alteplase | is a | standard of care | 0.90 | text |
| Alteplase | is a | most commonly used medication to treat pulmonary embolism | 0.90 | text |
| Alteplase | is a | thrombolytic medication | 0.90 | text |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.